2 completed, 2 recruiting, 1 withdrawn. 5 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 5 | Completed 2, Recruiting 2, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Withdrawn 1 |
Follow Primary Effusion Lymphoma: new trials by email Literature Review of Primary Effusion Lymphoma trials Research Report on Primary Effusion Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study") Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - AIDS-Related Diffuse Large B-cell Lymphoma, Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 1 | Recruiting | National Cancer Institute (NCI) | 15 | 2027-07-05 | 2026-11-05 |
| Study of SGR-1505 in Mature B-Cell Neoplasms SGR-1505 - Mature B-Cell Neoplasm, Non Hodgkin Lymphoma | Phase 1 | Recruiting | Schrödinger, Inc. | 98 | 2023-04-10 | 2026-02-13 |
| Lenalidomide Combined With Modified DA-EPOCH and Rituximab (EPOCH-R2) in Primary Effusion Lymphoma or KSHV-associated Large Cell Lymphoma Lenalidomide, Rituximab, Prednisone - Primary Effusion Lymphoma, B-Cell Neoplasm | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 17 | 2017-07-03 | 2026-11-12 |
| Study of Pomalidomide Combined With Modified DA-EPOCH and Rituximab in KSHV-Associated Lymphomas Pomalidomide, Rituximab, Prednisone - Large Cell Lymphoma Arising in KSHV-associated Multicentric Castleman Disease, Primary Effusion Lymphoma | Phase 1 / Phase 2 | Withdrawn | National Cancer Institute (NCI) | 2014-08-15 | 2018-08-31 | |
| Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas Cyclophosphamide, Doxorubicin Hydrochloride, Etoposide - AIDS-Related Plasmablastic Lymphoma, AIDS-Related Primary Effusion Lymphoma | Phase 1 / Phase 2 | Completed | National Cancer Institute (NCI) | 107 | 2010-10-06 | 2023-11-21 |
Lymphoma, Primary Effusion (5) · Plasmablastic Lymphoma (3) · Lymphoma, Follicular (2) · Lymphoma, Large B-Cell, Diffuse (2) · Burkitt Lymphoma (1) · HIV Infections (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma, AIDS-Related (1) · Lymphoma, B-Cell (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Pyloric Stenosis, Hypertrophic (1) · Waldenstrom Macroglobulinemia (1)
Hemic and Lymphatic Diseases (5) · Immune System Diseases (5) · Immunoproliferative Disorders (5) · Lymphatic Diseases (5) · Lymphoma (5) · Lymphoproliferative Disorders (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Lymphoma, B-Cell (4) · Lymphoma, Non-Hodgkin (4) · Infections (2) · Virus Diseases (2) · Blood Protein Disorders (1) · Blood-Borne Infections (1) · Cardiovascular Diseases (1)
Cyclophosphamide (4) · Doxorubicin (4) · Prednisone (4) · Rituximab (4) · Vincristine (4) · Etoposide (3) · CT-P10 (2) · deltacortene (2) · prednylidene (2) · Biopsy (1) · Bronchoscopy (1) · Echocardiography (1) · Electrocardiography (1) · Endoscopy (1) · Lenalidomide (1)
National Cancer Institute (NCI) (4) · Schrödinger, Inc. (1)
United States (4) · France (1) · Italy (1) · Moldova (1) · Poland (1) · Romania (1) · Spain (1) · Ukraine (1)
Frank G Basile, M.D. (1) · Juan C Ramos (1) · Ramya Ramaswami, MBBS, MPH (1) · Stefan K Barta (1) · Thomas S Uldrick, M.D. (1)
UM1CA121947 (2)